ESR1 and breast carcinoma: CT expression in HER2-positive versus HER2-negative breast cancers was compared between the ER-HER2+ and ER-HER2− groups to exclude potential influence of ER status, and all HER2+ and all HER2− cases were also compared in parallel (Figure 6).